Related Articles
Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)
Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
Pim-1 kinase as cancer drug target: An update (Review)
High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1‑α signaling pathway